Crossject (ALCJ) - Total Liabilities

Latest as of June 2025: €32.49 Million EUR ≈ $37.99 Million USD

Based on the latest financial reports, Crossject (ALCJ) has total liabilities worth €32.49 Million EUR (≈ $37.99 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Crossject to assess how effectively this company generates cash.

Crossject - Total Liabilities Trend (2010–2024)

This chart illustrates how Crossject's total liabilities have evolved over time, based on quarterly financial data. Check Crossject (ALCJ) asset resilience to evaluate the company's liquid asset resilience ratio.

Crossject Competitors by Total Liabilities

The table below lists competitors of Crossject ranked by their total liabilities.

Company	Country	Total Liabilities
Se Gyung Hi Tech Co.Ltd KQ:148150	Korea	₩92.50 Billion
Sedana Medical AB ST:SEDANA	Sweden	Skr53.68 Million
Eusu Holdings KO:000700	Korea	₩66.81 Billion
Merck Tbk JK:MERK	Indonesia	Rp154.71 Billion
Yuhwa Sec KO:003460	Korea	₩217.69 Billion
Cube Entertainment Inc KQ:182360	Korea	₩97.35 Billion
Nonthavej Hospital Public Company Limited BK:NTV	Thailand	฿366.81 Million
Macrogen Inc KQ:038290	Korea	₩173.25 Billion

Liability Composition Analysis (2010–2024)

This chart breaks down Crossject's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALCJ company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-15.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Crossject's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Crossject (2010–2024)

The table below shows the annual total liabilities of Crossject from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	€34.24 Million ≈ $40.03 Million	+0.97%
2023-12-31	€33.91 Million ≈ $39.64 Million	+12.38%
2022-12-31	€30.17 Million ≈ $35.28 Million	-18.46%
2021-12-31	€37.01 Million ≈ $43.26 Million	+6.58%
2020-12-31	€34.72 Million ≈ $40.59 Million	+61.63%
2019-12-31	€21.48 Million ≈ $25.11 Million	+16.08%
2018-12-31	€18.50 Million ≈ $21.63 Million	+59.11%
2017-12-31	€11.63 Million ≈ $13.60 Million	+46.01%
2016-12-31	€7.97 Million ≈ $9.31 Million	+56.75%
2015-12-31	€5.08 Million ≈ $5.94 Million	+30.64%
2014-12-31	€3.89 Million ≈ $4.55 Million	-17.28%
2013-12-31	€4.70 Million ≈ $5.50 Million	+4.54%
2012-12-31	€4.50 Million ≈ $5.26 Million	-10.71%
2011-12-31	€5.04 Million ≈ $5.89 Million	-54.46%
2010-12-31	€11.06 Million ≈ $12.93 Million	--

About Crossject

PA:ALCJ France Medical Instruments & Supplies

Market Cap

$116.85 Million

€99.95 Million EUR

Market Cap Rank

#18801 Global

#283 in France

Share Price

€1.90

Change (1 day)

-0.63%

52-Week Range

€1.02 - €2.69

All Time High

€10.40